Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study.
Aged
Female
Humans
Hyaluronic Acid
/ administration & dosage
Injections, Intra-Articular
Knee Joint
Male
Osteoarthritis, Knee
/ therapy
Oxygen
/ administration & dosage
Ozone
/ administration & dosage
Pain
Single-Blind Method
Treatment Outcome
Viscosupplements
/ administration & dosage
Visual Analog Scale
Osteoarthritis
hyaluronic acid
knee
oxygen-ozone therapy
ozone therapy
pain
Journal
Journal of back and musculoskeletal rehabilitation
ISSN: 1878-6324
Titre abrégé: J Back Musculoskelet Rehabil
Pays: Netherlands
ID NLM: 9201340
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
8
3
2020
medline:
3
11
2020
entrez:
8
3
2020
Statut:
ppublish
Résumé
There is little evidence on intra-articular (IA) treatment in knee osteoarthritis (KOA) and there is a lack of long-term follow-up studies. To assess the long-term effectiveness and safety of IA oxygen-ozone (O2O3) and hyaluronic acid (HA) in terms of functioning in KOA patients over a 31-week period. Patients aged ⩾ 60 years with KOA were randomly allocated to receive 4 IA knee injections (1/week) of O2O3 or HA (T0-T3) and a follow-up visit 4 weeks after the fourth injection (T4). In this extension study we assessed VAS and safety in patients with Visual Analogue Scale (VAS) ⩾ 4 at the at 6-month follow-up visit (T5), undergoing a second treatment cycle (T5-T8) and 1-month follow-up visit (T9). Forty-two patients (aged 70.5 ± 5.8 years) were randomly allocated to O2O3 (n= 22) or HA group (n= 20). Twenty-three underwent another IA cycle: 12 (54.6%) in the O2O3 group and 11 (55.0%) in the HA group. Both groups showed significant reduction in VAS (p< 0.013) compared to baseline during both cycles. At follow-up visits (T4 and T9), VAS was significantly lower in the HA group (p< 0.013). There were no differences in adverse events occurrence between groups. IA O2O3 might be comparable to HA in terms of effectiveness and safety in reducing pain in KOA patients, although at both follow-up visits (T4 and T9) VAS was significantly lower in the HA group.
Sections du résumé
BACKGROUND
BACKGROUND
There is little evidence on intra-articular (IA) treatment in knee osteoarthritis (KOA) and there is a lack of long-term follow-up studies.
OBJECTIVE
OBJECTIVE
To assess the long-term effectiveness and safety of IA oxygen-ozone (O2O3) and hyaluronic acid (HA) in terms of functioning in KOA patients over a 31-week period.
METHODS
METHODS
Patients aged ⩾ 60 years with KOA were randomly allocated to receive 4 IA knee injections (1/week) of O2O3 or HA (T0-T3) and a follow-up visit 4 weeks after the fourth injection (T4). In this extension study we assessed VAS and safety in patients with Visual Analogue Scale (VAS) ⩾ 4 at the at 6-month follow-up visit (T5), undergoing a second treatment cycle (T5-T8) and 1-month follow-up visit (T9).
RESULTS
RESULTS
Forty-two patients (aged 70.5 ± 5.8 years) were randomly allocated to O2O3 (n= 22) or HA group (n= 20). Twenty-three underwent another IA cycle: 12 (54.6%) in the O2O3 group and 11 (55.0%) in the HA group. Both groups showed significant reduction in VAS (p< 0.013) compared to baseline during both cycles. At follow-up visits (T4 and T9), VAS was significantly lower in the HA group (p< 0.013). There were no differences in adverse events occurrence between groups.
CONCLUSIONS
CONCLUSIONS
IA O2O3 might be comparable to HA in terms of effectiveness and safety in reducing pain in KOA patients, although at both follow-up visits (T4 and T9) VAS was significantly lower in the HA group.
Identifiants
pubmed: 32144974
pii: BMR181294
doi: 10.3233/BMR-181294
doi:
Substances chimiques
Viscosupplements
0
Ozone
66H7ZZK23N
Hyaluronic Acid
9004-61-9
Oxygen
S88TT14065
Types de publication
Comparative Study
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM